1084331-91-8

Upstream product

• 96606-37-0 2,4,6-trifluorobenzonitrile 
• 19962-06-2 tert-butyl 3-hydroxyphenylcarbamate 
• 1084333-33-4 C₁₈H₁₆F₂N₂O₃ 
• 29632-74-4 2-fluro-4-iodoaniline 

Downstream Products

• 1084332-06-8 {3-[2-carbamoyl-5-fluoro-3-(2-fluoro-4-iodo-phenylamino)-phenoxy]-phenyl}-carbamic acid tert-butyl ester 
• 1084332-21-7 2-(3-amino-phenoxy)-4-fluoro-6-(2-fluoro-4-iodo-phenylamino)-benzamide 
• 1084332-48-8 4-fluoro-2-(2-fluoro-4-iodo-phenylamino)-6-(3-methanesulfonylamino-phenoxy)-benzamide 
• 1084332-49-9 4-fluoro-2-(2-fluoro-4-iodo-phenylamino)-6-(3-bis-methanesulfonylamino-phenoxy)-benzamide 

Relevant academic research and scientific papers

SUBSTITUTED SULPHONAMIDO PHENOXYBENZAMIDES

The present invention relates to substituted sulphonamido phenoxybenzamide compounds of general formula (I) in which A, R1, R2, R3, R4, R5, R6, R7, R8 and n are as defined in the claims, to pharmaceutical compositions and combinations containaining said compounds, to methods of preparing said compounds, and to the use of said compounds or compositions for treating hyper- proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.

SUBSTITUTED AMIDO PHENOXYBENZAMIDES

The present invention relates to substituted amido phenoxybenzamide compounds of general formula (I) in which A, R1, R2, R3, R4, R5, R6, R7, R8, R9 and n are as defined in the claims, to pharmaceutical compositions and combinations containing said compounds, to methods of preparing said compounds, and to the use of said compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.

SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY

This invention relates to novel substituted phenylamino-benzene compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper- proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.